Ethical Dilemmas: CDU Inc. And Steve Brenda

Deciding right or wrong is an ethical dilemma faced by everyone. Recently, a wall street financial analyst, Martin Shkreli was under the negative light of the public where he overcharged the price of important drugs. Similarly, looking at the case of CDU Inc., when it got acquired by a financial analyst, Steve Brenda; the organization experienced a change in the corporate culture where the motto is “maximum profit at minimum cost”, it led to CDU Inc.’s crisis.

Legally and ethically, CDU Inc. and Steve Brenda have a situation on their hands. Steve Brenda led his organization with his financial analyst mindset and observed the opportunity to maximize profits in the pharmaceutical sector. However, Brenda’s approach towards the Pharmaceutical
With the substantial increase in the price of the drug, it changes the whole scenario because there is no other drug as effective as CDU Inc.’s B-52, which in turn goes against the guidelines of Review Board. Even though there have been hearings and warnings issued against CDU Inc. and Steve Brenda, Steve has been indifferent towards and/or all summoning.
One can argue that Steve Brenda’s actions are unethical. By fostering a culture of “maximum profit at minimum cost” and ignoring everyone by adopting a bottom line of “damn the torpedoes, full speed ahead”, Brenda’s actions have led his company into a situation where they are breaching the contract. The bigger picture in this scenario is that Brenda is fully aware that his company’s B-52 drug is the most effective drug on the market to aid HIV/AIDS patients; using this knowledge, he exploits the patients in discomfort by asking them to pay for the drug at an increase of 8000%. His justification is that the patients have no choice other than purchasing the drug at an over-inflated price which allows him to maximize his